Protagonist Therapeutics Inc (PTGX)
41.65
+1.00
(+2.46%)
USD |
NASDAQ |
Nov 21, 16:00
41.69
+0.04
(+0.10%)
After-Hours: 20:00
Protagonist Therapeutics Max Drawdown (5Y): 85.79% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 85.79% |
| September 30, 2024 | 85.79% |
| August 31, 2024 | 85.79% |
| July 31, 2024 | 85.79% |
| June 30, 2024 | 85.79% |
| May 31, 2024 | 85.79% |
| April 30, 2024 | 85.79% |
| March 31, 2024 | 85.79% |
| February 29, 2024 | 85.79% |
| January 31, 2024 | 85.79% |
| December 31, 2023 | 85.79% |
| November 30, 2023 | 85.79% |
| October 31, 2023 | 85.79% |
| September 30, 2023 | 85.79% |
| August 31, 2023 | 85.79% |
| July 31, 2023 | 85.79% |
| June 30, 2023 | 85.79% |
| May 31, 2023 | 85.79% |
| April 30, 2023 | 85.79% |
| March 31, 2023 | 85.79% |
| February 28, 2023 | 85.79% |
| January 31, 2023 | 85.79% |
| December 31, 2022 | 85.79% |
| November 30, 2022 | 85.79% |
| October 31, 2022 | 85.79% |
| Date | Value |
|---|---|
| September 30, 2022 | 85.79% |
| August 31, 2022 | 85.79% |
| July 31, 2022 | 85.79% |
| June 30, 2022 | 85.79% |
| May 31, 2022 | 84.50% |
| April 30, 2022 | 82.13% |
| March 31, 2022 | 82.13% |
| February 28, 2022 | 82.13% |
| January 31, 2022 | 82.13% |
| December 31, 2021 | 82.13% |
| November 30, 2021 | 82.13% |
| October 31, 2021 | 82.13% |
| September 30, 2021 | 82.13% |
| August 31, 2021 | 82.13% |
| July 31, 2021 | 82.13% |
| June 30, 2021 | 82.13% |
| May 31, 2021 | 82.13% |
| April 30, 2021 | 82.13% |
| March 31, 2021 | 82.13% |
| February 28, 2021 | 82.13% |
| January 31, 2021 | 82.13% |
| December 31, 2020 | 82.13% |
| November 30, 2020 | 82.13% |
| October 31, 2020 | 82.13% |
| September 30, 2020 | 82.13% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
77.17%
Minimum
Nov 2019
85.79%
Maximum
Jun 2022
83.86%
Average
83.32%
Median
Max Drawdown (5Y) Benchmarks
| Johnson & Johnson | 27.36% |
| Assembly Biosciences Inc | 98.41% |
| Precision BioSciences Inc | -- |
| Entrada Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -2.580 |
| Beta (5Y) | 2.170 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.52% |
| Historical Sharpe Ratio (5Y) | 0.2635 |
| Historical Sortino (5Y) | 0.4585 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.81% |